Inflammatory sites as a source of plasma neopterin: Measurement of high levels of neopterin and markers of oxidative stress in pus drained from human abscesses

Clinical Biochemistry

Volumn 41, Issue 13, 2008, Pages 1078-1083

  Firth, Carole A ^a   Laing, Andrew D ^b   Baird, Sarah K ^a   Pearson, Joseph ^a   Gieseg, Steven P ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

7,8 Dihydroneopterin; Inflammation; Neopterin; Protein bound DOPA; Protein oxidation; Pus; TBARS; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; CARBONYL DERIVATIVE; DITYROSINE; DOPA; NEOPTERIN; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ABSCESS; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MALE; NEEDLE BIOPSY; OXIDATIVE STRESS; PRIORITY JOURNAL; PUS; QUANTITATIVE ANALYSIS;

ABSCESS; ADULT; AGED; AGED, 80 AND OVER; ALPHA-TOCOPHEROL; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPTERIN; SUPPURATION; TYROSINE;

EID: 49349089059     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.06.008     Document Type: Article

References (45)

1. Huber C., Batchelor J.R., Fuchs D., Hausen A., Lang A., Niederwieser D., et al. Immune response associated production of neopterin-Release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 160 (1984) 310-316
2. Gieseg S.P., Crone E.M., Flavall E.A., and Amit Z. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis. Br. J. Pharmacol. 153 (2008)
3. Flavall E.A., Crone E.M., Moore G.A., and Gieseg S.P. Dissociation of neopterin and 7,8-dihydroneopterin from plasma components before HPLC analysis. J. Chromatogr. B. 863 (2008) 167-171
4. Mildvan D., Spritzler J., Grossberg S.E., Fahey J.L., Johnston D.M., Schock B.R., et al. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced hiv-1 infection. Clin. Infect. Dis. 40 (2005) 853-858
5. Sahin M., Varol E., Ozaydin M., Altinbas A., Aydin O., Aslan S.M., et al. Comparison of neopterin levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease. South Med. J. 101 (2008) 476-479
6. Ray K.K., Morrow D.A., Sabatine M.S., Shui A., Rifai N., Cannon C.P., et al. Long-term prognostic value of neopterin a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 115 (2007) 3071-3078
7. Tatzber F., Rabl H., Koriska K., Erhart U., Puhl H., Weag G., et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 89 (1991) 203-208
8. Erren M., Reinecke H., Junker R., Fobker M., Schulte H., Schurek J.O., et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arteriosclerosis Thombosis. Vasc.Biol. 10 (1999) 2355-2363
9. Avanzas P., Arroyo-Espliguero R., Cosin-Sales J., Aldama G., Pizzi C., Quiles J., et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 90 (2004) 847-852
10. Duggan S., Rait C., Gebicki J.M., and Gieseg S.P. Inhibition of protein oxidation by the macrophage synthesised antioxidant 7,8-dihydroneopterin. Redox Report 6 (2001) 188-190
11. Gieseg S.P., Glubb D., and Maghzal G. Protection of erythrocytes by the macrophage synthesized antioxidant 7,8 dihydroneopterin. Free Radic. Res. 34 (2001) 123-136
12. Gieseg S.P., Whybrow J., Glubb D., and Rait C. Protection of U937 cells from free radical damage by the macrophage synthesized antioxidant 7,8 dihydroneopterin. Free Radic. Res 35 (2001) 311-318
13. Gieseg S.P., Duggan S., Rait C., and Platt A. Protein and thiol oxidation in cells exposed to peroxyl radicals, is inhibited by the macrophage synthesised pterin 7,8-dihydroneopterin. Biochim. Biophys. Acta 1591 (2002) 139-145
14. Baird S.K., Reid L., Hampton M., and Gieseg S.P. OxLDL induced cell death is inhibited by the macrophage synthesised pterin, 7,8-dihydroneopterin, in U937 cells but not THP-1 cells. Biochim Biophys. Acta 1745 (2005) 361-369
15. Gieseg S.P., Reibnegger G., Wachter H., and Esterbauer H. 7,8-Dihydroneopterin inhibits low density lipoprotein oxidation in vitro. Evidence that this macrophage secreted pteridine is an antioxidant. Free Radic. Res. 23 (1995) 123-136
16. Firth C.A., Yang Y., and Gieseg S.P. Lipid oxidation predominates over protein hydroperoxide formation in human monocyte-derived macrophages exposed to aqueous peroxyl radicals. Free Radic. Res. 41 (2007) 839-848
17. Oettl K., Dikalov S., Freisleben H.J., Mlekusch W., and Reibnegger G. Spin trapping study of antioxidant properties of neopterin and 7,8-dihydroneopterin. Biochem. Biophys. Res. Commmun. 234 (1997) 774-778
18. Gieseg S.P., Pearson J., and Firth C.A. Protein hydroperoxides are a major product of low density lipoprotein oxidation during copper, peroxyl radical and macrophage-mediated oxidation. Free Radic. Res. 37 (2003) 983-991
19. Heales S.J.R., Blair J.A., Meinschard C., and Ziegler I. Inhibition of monocyte luminol-dependent chemiluminescence by tetrahydrobiopterin and free radical oxidation of tetrahydrobiopterin, dihydrobiopterin and dihydroneopterin. Cell Biochem. Funct. 6 (1988) 191-195
20. Baier-Bitterlich G., Fuchs D., Murr C., Reibnegger G., Werner-Felmayer G., Sgonc R., et al. Effect of neopterin and 7,8-dihydroneopterin on tumor necrosis factor-alpha induced programmed cell death. FEBS Lett. 364 (1995) 234-238
21. Oettl K., and Reibnegger G. Pteridine derivatives as modulators of oxidative stress. Curr. Drug Metab. 3 (2002) 203-209
22. Enzinger C., Wirleitner B., Spottl N., Bock G., Fuchs D., and Baier-Bitterlich G. Reduced pteridine derivatives induce apoptosis in PC12 cells. Neurochem. Int. 41 (2002) 71-78
23. Wirleitner B., Obermoser G., Bock G., Neurauter G., Schennach H., Sepp N., et al. Induction of apoptosis in human blood T cells by 7,8-dihydroneopterin: the difference between healthy controls and patients with systemic lupus erythematosus. Clin. Immunol. 107 (2003) 152-159
24. Oettl K., Wirleitner B., Baier-Bitterlich G., Grammer T., Fuchs D., and Reibnegger G. Formation of oxygen radicals in solutions of 7,8-dihydroneopterin. Biochem. Biophys. Res. Commun. 264 (1999) 262-267
25. Wirleitner B., Czaputa R., Oettl K., Bock G., Widner B., Reibnegger G., et al. Induction of apoptosis by 7,8-dihydroneopterin: involvement of radical formation. Immunobiology 203 (2001) 629-641
26. Greilberger J., Oettl K., Cvirn G., Reibnegger G., and Jurgens G. Modulation of LDL oxidation by 7,8-dihydroneopterin. Free Radic. Res. 38 (2004) 9-17
27. Giulivi C., and Davies K.J.A. Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19S) proteasome. J. Biol. Chem. 268 (1993) 8752-8759
28. Pichorner H., Metodiewa D., and Winterbourn C. Generation of superoxide and tyrosine peroxide as a result of tyrosyl radical scavenging by glutathione. Arch. Biochem. Biophys. 323 (1995) 429-437
29. Fu S., Davies M., Stocker R., and Dean R.T. Evidence for role of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem. J. 333 (1998) 519-525
30. Zeitler H., and Andondonskaja-Renz B. Separation of pteridines from blood cells and plasma by reverse phase high performance liquid chromatography. Methods Enzymol. 122 (1986) 272-295
31. Gieseg S.P., Simpson J.A., Charlton T.S., Duncan M.W., and Dean R.T. Protein bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. Biochemistry 32 (1993) 4780-4786
32. Sutherland W.H.F., Gieseg S.P., Walker R.J., De Jong S.A., Firth C.A., and Scott N. Serum protein-bound 3,4-dihydroxyphenylalanine and related products of protein oxidation and chronic hemodialysis. Ren. Fail 25 (2003) 997-1009
33. Esterbauer H., Jurgens G., Quehenberger O., and Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28 (1987) 495-509
34. Quinlan G.J., Evans T.W., and Gutteridge J.M.C. Oxidative damage to plasma proteins in adult respiratory distress syndrome. Free Radic. Res. 20 (1994) 289-298
35. Draper H.H., Squires E.J., Mahmoodi H., Wu J., Agarwal S., and Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic. Biol. Med. 15 (1993) 353-363
36. Jentzsch A.M., Bachmenn H., Furst P., and Biesalski H.K. Improved analysis of malondialdehyde in human body fluids. Free Radic. Biol. Med. 20 (1996) 251-256
37. Strohmaier W., Poigenfurst J., and Mauritz W. Neopterin blood levels: a basis for deciding to use antibiotics in intensive care unit (ICU) patients. Pteridines 7 (1996) 1-4
38. Akbulut H.H., Celik I., Akbulut A., Yuce P., and Kilic S.S. Serum neopterin levels in patients with brucellosis. J. Infect. 51 (2005) 281-286
39. Schroecksnadel K., Frick B., Kaser S., Wirleitner B., Ledochowski M., Mur E., et al. Moderate hyperhomocysteinaemia and immune activation in patients with rheumatoid arthritis. Clin. Chim. Acta 338 (2003) 157-164
40. Gieseg S.P., and Cato S. Inhibition of THP-1 cell-mediated low-density lipoprotein oxidation by the macrophage-synthesised pterin, 7,8-dihydroneopterin. Redox Rep. 8 (2003) 113-119
41. Firth C.A., Crone E.M., Flavall E.A., Roake J., and Gieseg S.P. Macrophage mediated protein hydroperoxide formation and lipid oxidation in low density lipoprotein is inhibited by the inflammation marker 7,8 dihydroneopterin. Biochemica et Biophysica Acta-Molecular Cell Research 1783 (2008) 1095-1101
42. Dean R.T., Gieseg S.P., and Davies M.J. Reactive species and their accumulation on radical-damaged proteins. Trends in Biochemical Science 18 (1993) 437-441
43. Pattison D.I., Dean R.T., and Davies M.J. Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. Toxicology 177 (2002) 23-37
44. Niu X.W., Zammit V., Upston J.M., Dean R.T., and Stocker R. Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques. Arterioscler Thromb Vasc. Biol. 19 (1999) 1708-1718
45. Upston J.M., Niu X., Brown A.J., Mashima R., Wang H., Senthilmohan R., et al. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am. J. Pathol. 160 (2002) 710-720